Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 2,422,900 | 2,294,000 | 1,952,000 | 1,828,200 | 1,863,500 |
| Cost of Goods | 353,100 | 274,000 | 275,500 | 217,300 | 221,700 |
| Gross Profit | 2,069,800 | 2,020,000 | 1,676,500 | 1,610,900 | 1,641,800 |
| Operating Expenses | 902,900 | 966,900 | 1,020,600 | 911,100 | 966,800 |
| Operating Income | 1,167,000 | 1,053,100 | 656,400 | 700,100 | 675,700 |
| Interest Expense | 14,800 | 26,300 | 9,700 | 6,100 | 6,700 |
| Other Income | 72,400 | -28,500 | 272,200 | -25,400 | 220,800 |
| Pre-tax Income | 1,224,600 | 998,300 | 918,900 | 668,600 | 889,800 |
| Income Tax | 75,400 | 156,200 | 21,600 | 44,000 | 97,800 |
| Net Income Continuous | 1,149,200 | 842,100 | 897,300 | 624,600 | 792,000 |
| Net Income | $1,149,200 | $842,100 | $897,300 | $624,600 | $792,000 |
| EPS Basic Total Ops | 10.79 | 7.98 | 8.19 | 5.69 | 7.26 |
| EPS Basic Continuous Ops | 10.79 | 7.98 | 8.19 | 5.69 | 7.25 |
| EPS Diluted Total Ops | 10.09 | 7.39 | 7.61 | 5.43 | 6.93 |
| EPS Diluted Continuous Ops | 10.09 | 7.39 | 7.61 | 5.43 | 6.92 |
| EBITDA(a) | $1,228,700 | $1,112,400 | $715,200 | $756,200 | $730,001 |